ArriVent BioPharma (AVBP) Return on Capital Employed [ROCE] (2024 - 2026)
ArriVent BioPharma's Return on Capital Employed [ROCE] came in at -51.12% for Q2 2026, up 15.44 percentage points from -66.56% a year earlier but down 1.52 percentage points from the prior quarter.
Powered by 
Analysis
ArriVent BioPharma (AVBP) Return on Capital Employed [ROCE] (2024 - 2026) Analysis & Trends
For FY2025, ArriVent BioPharma's Return on Capital Employed [ROCE] was -63.84%, down 17.09 percentage points from FY2024.
- Going back by year, Return on Capital Employed [ROCE] was -46.75% in FY2024.
- The five-year range for quarterly Return on Capital Employed [ROCE] is -66.56% (Q2 2025) to -28.15% (Q2 2024).
- Year-over-year, Return on Capital Employed [ROCE] increased in two of the last six quarters, with an average year-over-year change of -14.38 percentage points.
- Business Quant data shows AVBP's Return on Capital Employed [ROCE] at -49.61% (Q1 2026), -58.42% (Q4 2025) and -58.75% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | ArriVent BioPharma | 1.37 Bn | 1.37 Bn | - | -51.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -51.12% |
| Mar 31, 2026 | -49.61% |
| Dec 31, 2025 | -58.42% |
| Sep 30, 2025 | -58.75% |
| Jun 30, 2025 | -66.56% |
| Mar 31, 2025 | -60.45% |
| Dec 31, 2024 | -35.38% |
| Sep 30, 2024 | -32.81% |
| Jun 30, 2024 | -28.15% |
| Mar 31, 2024 | -35.28% |
API Access
ArriVent BioPharma Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AVBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "AVBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AVBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();